Towards a shared language for pharmacists prescribing: Why terminology matters

Pharmacist prescribing has expanded rapidly across many health systems as governments seek to improve access to care and optimise medicines use. However, policy development and evaluation of these initiatives are impeded by inconsistent and ambiguous use of terminology describing prescribing, scope of practice, and models of pharmacist involvement. This commentary discusses the concept of prescribing as a regulated act constituted by four interdependent elements: the medicine, the condition, the prescriber, and the regulatory authority that authorizes practice. Terms such as minor ailments, common conditions, independent prescribing, autonomous prescribing, and collaborative or supplementary prescribing are variably applied across jurisdictions, often conflating prescribing with broader clinical management activities. It is argued that such imprecision obscures professional accountability, complicates interprofessional boundary setting, and undermines coherent regulatory governance. The paper discusses the need for a standardised terminology that is applicable across health professions and prescribing models, rather than pharmacy-specific labels. Clarifying the conceptual and regulatory meaning of prescribing is positioned as a prerequisite for effective policy design, implementation, and evaluation of expanded community pharmacy services. Establishing a shared language will support transparent allocation of clinical responsibility, improve system integration, and enable robust assessment of safety, and equity.